General
Experience17 yrs
Elite Ratings
--
Practice Areas
Biotech (68 cases)
Mech Eng, Manuf (7 cases)
Chemical Biotech (4 cases)
Chemical (4 cases)
Communications (3 cases)
Ratings
Experience
Grade
Trend
DCT
L2
C
PTAB
--
--
--
CAFC
--
--
--
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 1:24-CV-00067 | Novo Nordisk Inc v. Mylan Pharma Inc | 07/02/24 | Patent Owner | |
| 1:23-CV-00013 | Novo Nordisk Inc v. Viatris Inc | 01/27/23 | Patent Owner | |
| 1:22-CV-01040 | Novo Nordisk Inc v. Mylan Pharma Inc | 08/08/22 | ||
| 1:22-MD-03038 | In re: Ozempic (Semaglutide) Patent Litigation | 08/05/22 | Patent Owner | |
| 1:22-CV-00035 | AstraZeneca Ab v. Mylan Pharma Inc | 04/26/22 | ||
| 1:22-CV-00451 | Novartis Pharma Corp v. Mylan Pharma Inc | 04/05/22 | Patent Owner | |
| 1:22-CV-00023 | Novo Nordisk v. Mylan | 03/18/22 | Patent Owner | |
| 1:21-CV-00146 | Novartis Pharma Corp v. Mylan Pharma Inc | 12/20/21 | Patent Owner | |
| 1:21-CV-00839 | PF Prism Imb BV v. Mylan Pharma Inc | 06/09/21 | Patent Owner | |
| 1:20-CV-00244 | Pfizer Inc v. Mylan Pharma Inc | 10/16/20 | Patent Owner |